United Theranostics is a national private practice dedicated to molecular imaging and precision radiopharmaceutical therapy for cancer treatment. With an ambitious plan to establish clinics in all 50 states by 2030, the company aims to make advanced theranostics care and clinical trials widely accessible to patients in a comfortable, outpatient setting. They are committed to compassionate care by redefining nuclear medicine practice, integrating imaging and treatment to offer individualized plans for various cancers, including metastatic prostate, neuroendocrine, and thyroid cancers, ensuring a patient-centered approach to healing.
